Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25207

1.

A quantitative model of human neurodegenerative diseases involving protein aggregation.

Kepp KP.

Neurobiol Aging. 2019 Apr 10;80:46-55. doi: 10.1016/j.neurobiolaging.2019.04.001. [Epub ahead of print]

PMID:
31102901
2.

In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis.

Bonifacino T, Provenzano F, Gallia E, Ravera S, Torazza C, Bossi S, Ferrando S, Puliti A, Van Den Bosch L, Bonanno G, Milanese M.

Neurobiol Dis. 2019 May 15. pii: S0969-9961(19)30121-4. doi: 10.1016/j.nbd.2019.05.007. [Epub ahead of print]

PMID:
31102766
3.

Effects of continuous high-dose G-CSF administration on hematopoietic stem cell mobilization and telomere length in patients with amyotrophic lateral sclerosis - a pilot study.

Iberl S, Meyer AL, Müller G, Peters S, Johannesen S, Kobor I, Beier F, Brümmendorf TH, Hart C, Schelker R, Herr W, Bogdahn U, Grassinger J.

Cytokine. 2019 May 14;120:192-201. doi: 10.1016/j.cyto.2019.05.003. [Epub ahead of print]

PMID:
31100684
4.

TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response.

Wang P, Deng J, Dong J, Liu J, Bigio EH, Mesulam M, Wang T, Sun L, Wang L, Lee AY, McGee WA, Chen X, Fushimi K, Zhu L, Wu JY.

PLoS Genet. 2019 May 17;15(5):e1007947. doi: 10.1371/journal.pgen.1007947. eCollection 2019 May.

5.

The role of neurofilament aggregation in neurodegeneration: lessons from rare inherited neurological disorders.

Didonna A, Opal P.

Mol Neurodegener. 2019 May 16;14(1):19. doi: 10.1186/s13024-019-0318-4. Review.

6.

Transcriptomic Analysis of MAPK Signaling in NSC-34 Motor Neurons Treated with Vitamin E.

Chiricosta L, Gugliandolo A, Tardiolo G, Bramanti P, Mazzon E.

Nutrients. 2019 May 15;11(5). pii: E1081. doi: 10.3390/nu11051081.

7.

Is the evidence strong enough for acupuncture ameliorates clinical symptoms in patients with amyotrophic lateral sclerosis: A protocol for a systematic review and meta-analysis.

Liao Q, Li Z, Zeng H, Feng X, Huang W, Fu C, Liang X, Li T.

Medicine (Baltimore). 2019 May;98(20):e15218. doi: 10.1097/MD.0000000000015218.

8.

Modification of the gut microbiome to combat neurodegeneration.

Sasmita AO.

Rev Neurosci. 2019 May 16. pii: /j/revneuro.ahead-of-print/revneuro-2019-0005/revneuro-2019-0005.xml. doi: 10.1515/revneuro-2019-0005. [Epub ahead of print]

PMID:
31095511
9.

The Promise and Perils of Compound Discovery Screening with Inducible Pluripotent Cell-Derived Neurons.

Sharlow ER, Koseoglu MM, Bloom GS, Lazo JS.

Assay Drug Dev Technol. 2019 May 16. doi: 10.1089/adt.2019.914. [Epub ahead of print]

PMID:
31095406
10.

An endogenous peptide marker differentiates SOD1 stability and facilitates pharmacodynamic monitoring in SOD1 amyotrophic lateral sclerosis.

Gertsman I, Wuu J, McAlonis-Downes M, Ghassemian M, Ling K, Rigo F, Bennett F, Benatar M, Miller TM, Da Cruz S.

JCI Insight. 2019 May 16;4(10). pii: 122768. doi: 10.1172/jci.insight.122768. eCollection 2019 May 16.

11.

The RNA-binding protein FUS/TLS undergoes calcium-mediated nuclear egress during excitotoxic stress and is required for GRIA2 mRNA processing.

Tischbein M, Baron DM, Lin YC, Gall KV, Landers JE, Fallini C, Bosco DA.

J Biol Chem. 2019 May 15. pii: jbc.RA118.005933. doi: 10.1074/jbc.RA118.005933. [Epub ahead of print]

12.

Amyotrophic lateral sclerosis type 8 is not a pure motor disease: evidence from a neuropsychological and behavioural study.

de Alcântara C, Cruzeiro MM, França MC Jr, Camargos ST, de Souza LC.

J Neurol. 2019 May 14. doi: 10.1007/s00415-019-09369-y. [Epub ahead of print]

PMID:
31089860
13.

Adipose-derived stem cell conditioned medium for the treatment of amyotrophic lateral sclerosis: pre-clinical evidence and potential for clinical application.

Walker CL.

Neural Regen Res. 2019 Sep;14(9):1522-1524. doi: 10.4103/1673-5374.253514. No abstract available.

PMID:
31089048
14.

Fungal-contaminated grass and well water and sporadic amyotrophic lateral sclerosis.

French PW, Ludowyke RI, Guillemin GJ.

Neural Regen Res. 2019 Sep;14(9):1490-1493. doi: 10.4103/1673-5374.255959. Review.

PMID:
31089037
15.
16.

Medical hypothesis: Neurodegenerative diseases arise from oxidative damage to electron tunneling proteins in mitochondria.

Bennett JP.

Med Hypotheses. 2019 Jun;127:1-4. doi: 10.1016/j.mehy.2019.03.034. Epub 2019 Mar 28.

PMID:
31088629
17.

Antibiotics Use and Risk of Amyotrophic Lateral Sclerosis in Sweden.

Sun J, Zhan Y, Mariosa D, Larsson H, Almqvist C, Ingre C, Zagai U, Pawitan Y, Fang F.

Eur J Neurol. 2019 May 14. doi: 10.1111/ene.13986. [Epub ahead of print]

PMID:
31087715
18.

Oligogenic basis of sporadic ALS: The example of SOD1 p.Ala90Val mutation.

Kuuluvainen L, Kaivola K, Mönkäre S, Laaksovirta H, Jokela M, Udd B, Valori M, Pasanen P, Paetau A, Traynor BJ, Stone DJ, Schleutker J, Pöyhönen M, Tienari PJ, Myllykangas L.

Neurol Genet. 2019 Apr 23;5(3):e335. doi: 10.1212/NXG.0000000000000335. eCollection 2019 Jun.

19.

C9ORF72-ALS/FTD-associated poly(GR) binds Atp5a1 and compromises mitochondrial function in vivo.

Choi SY, Lopez-Gonzalez R, Krishnan G, Phillips HL, Li AN, Seeley WW, Yao WD, Almeida S, Gao FB.

Nat Neurosci. 2019 May 13. doi: 10.1038/s41593-019-0397-0. [Epub ahead of print]

PMID:
31086314
20.

Cannabis Hyperemesis Syndrome in Palliative Care: A Case Study and Narrative Review.

Howard I.

J Palliat Med. 2019 May 14. doi: 10.1089/jpm.2018.0531. [Epub ahead of print]

PMID:
31084461

Supplemental Content

Loading ...
Support Center